wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37301465-5155B310-CF4F-4117-B141-0B3B4AA545EC
Q37301465-5155B310-CF4F-4117-B141-0B3B4AA545EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37301465-5155B310-CF4F-4117-B141-0B3B4AA545EC
Optimizing tyrosine kinase inhibitor therapy in gastrointestinal stromal tumors: exploring the benefits of continuous kinase suppression.
P2860
Q37301465-5155B310-CF4F-4117-B141-0B3B4AA545EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37301465-5155B310-CF4F-4117-B141-0B3B4AA545EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ebdaca940d25f63878ae3a65d292ac8288e94f28
P2860
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.